MISSISSAUGA, ON, Nov. 4, 2014 /CNW/ - Baxter Corporation today announced it is investing $10 million to build a new facility in Mississauga, Ontario for its Centralized Intravenous Admixing Pharmacy ...
SUGAR LAND, Texas, Dec. 13, 2018 /PRNewswire/ -- QuVa Pharma, Inc. a leading FDA registered 503B outsourcing provider of "ready-to-use" compounded I.V. products, announced today that it has been ...
Identification of genetic variants that contribute to risk of hypertension is challenging. As a complement to linkage and candidate gene association studies, we carried out admixture mapping using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results